Introduction     Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease Karen L. Bell, M.D.     Treatment Strategies for Dementia and Mild Cognitive Impairment Mary Sano, Ph.D.     Treatment of Depression, Agitation, and Psychosis in Dementia Davangere P. Devanand, M.D.     Recognition of Vascular Dementia, Dementia with Lewy Bodies, and Frontotemporal Dementia Lawrence S. Honig, M.D., Ph.D.     Neuropsychology of Mild Cognitive Impairment, Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia Penne Sims, Ph.D.     Neuroimaging in Dementia Scott A. Small, M.D.     Genetics of Neurodegenerative Disease: Alzheimer's Disease, Frontotemporal Dementia Jennifer Williamson-Catania, M.S.     Legal and Ethical Issues for Patients with Dementia Daniel G. Fish, Esq.     Posttest         Accreditation     Reference List     Acknowledgements		Accreditation Release Date: March 1, 2004 Valid for Credit through: March 1, 2006 Target Audience: Primary-care practitioners, neurologists, and psychiatrists Learning Objective: In this online CME course, you will learn about diagnosis and current treatment options for cognitive and behavioral disorders associated with Alzheimer's disease and related dementias diagnosis and management of Alzheimer's disease, vascular dementia, frontotemporal dementia, and dementia with Lewy bodies the role of genetic testing for dementia legal and ethical issues for Alzheimer's disease After completion of this course, you should: be familiar with the distinctions between dementia and mild cognitive impairment be aware of the findings on history, examination, and laboratory tests for AD and related disorders be familiar with the findings on structural and functional brain imaging in mild cognitive impairment, Alzheimer's disease, and related disorders understand role of neuropsychological testing in screening for mild cognitive impairment and dementia and be familiar with mental-status screening tests for use in clinical practice be up-to-date on current treatment modalities for the cognitive and behavioral symptoms of Alzheimer's disease practice be knowledgeable of the role of genetics in Alzheimer's disease and frontotemporal dementia be able to provide information to patients and families regarding legal and ethical issues Accreditation Information Physicians The College of Physicians and Surgeons of Columbia University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. The College of Physicians and Surgeons designates this educational activity for a maximum of 4.5 category-one credits towards the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity. This program has been planned and produced in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). Program Number tbd Dementia: Update for the Practitioner Disclosure Statement As an accredited sponsor, the College of Physicians and Surgeons must ensure balance, independence, objectivity, and scientific rigor in its educational activities. All faculty participating in this activity are required to disclose to the audience any significant financial interest and/or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in his/her presentation and/or the commercial contributor(s) of this activity. Karen L. Bell, M.D. Speaker's Bureau   Ortho-McNeil Pharmaceutical Davangere P. Devanand, M.D.* Consultant   Novartis Pharmaceuticals Corp.   Janssen Pharmaceutical, Inc.   Organon Research Support   Pfizer, Inc.   Wyeth Daniel G. Fish, Esq. None Lawrence S. Honig, M.D., Ph.D.* Speaker's Bureau   Janssen Pharmaceutical, Inc.   Ortho-McNeil Pharmaceutical   Pfizer, Inc.   Eisai   Novartis Pharmaceuticals Corp. Other Financial Support   Janssen Pharmaceutical, Inc.   Ortho-McNeil Pharmaceutical Mary Sano, Ph.D. Consultant   Forest   Pfizer, Inc   Merck   Janssen Penne Sims, Ph.D. None Scott A. Small, M.D. None Jennifer Williamson-Catania, M.S. none An asterisk after the speaker's name indicates that the speaker discusses unlabeled uses of a commercial product or an investigational use of a product not yet approved for this purpose. The speaker discloses this information during his/her presentation. Disclaimer Any procedures, medications, or other course of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. This CME activity is supported by Janssen Pharmaceutica.